{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:32:20Z","timestamp":1788255140130,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000827","name":"Royal Pharmaceutical Society of Great Britain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.contraception.2010.06.013","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T04:51:58Z","timestamp":1284612718000},"page":"16-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["The use of hormonal contraception among women taking anticonvulsant therapy"],"prefix":"10.1016","volume":"83","author":[{"given":"Mary E.","family":"Gaffield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Culwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Rhoda","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.06.013_bb0005","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/bmj.1.5801.686-c","article-title":"Unplanned pregnancy in an epileptic","volume":"1","author":"Kenyon","year":"1972","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2010.06.013_bb0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003088-200746020-00003","article-title":"Pharmacokinetic drug interactions involving 17\u00e1-ethinylestradiol","volume":"46","author":"Zhang","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2010.06.013_bb0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1474-4422(05)70224-6","article-title":"Birth defects after prenatal exposure to antiepileptic drugs","volume":"4","author":"Perucca","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.contraception.2010.06.013_bb0020","article-title":"Pregnancy and epilepsy: what should we tell our patients?","author":"Tomson","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.contraception.2010.06.013_bb0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0035","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/01.wnl.0000238522.79277.9c","article-title":"Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives","volume":"67","author":"Tomson","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2010.06.013_bb0040","series-title":"Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.contraception.2010.06.013_bb0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2005.02.008","article-title":"Keeping up with evidence: a new system for WHOs' evidence-based family planning guidance","volume":"28","author":"Mohllajee","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2010.06.013_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2010.06.013_bb0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0010-7824(80)90102-X","article-title":"The interaction of Phenobarbital and other anticonvulsants with oral contraceptive steroid therapy","volume":"22","author":"Back","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.06.013_bb0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.1988.tb03341.x","article-title":"Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics","volume":"25","author":"Back","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2010.06.013_bb0065","first-page":"3008","article-title":"Influence de certains m\u00e9dicaments sur l'action des pilules contraceptives","volume":"4","author":"Belaisch","year":"1976","journal-title":"Nouv Presse Med"},{"key":"10.1016\/j.contraception.2010.06.013_bb0070","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1528-1167.2006.00558.x","article-title":"Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy","volume":"47","author":"Contin","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1528-1157.1979.tb04834.x","article-title":"Do anticonvulsants reduce the efficacy of oral contraceptives?","volume":"20","author":"Coulam","year":"1979","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0010-7824(86)90028-4","article-title":"The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids","volume":"33","author":"Crawford","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.06.013_bb0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids","volume":"30","author":"Crawford","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2010.06.013_bb0090","first-page":"1485","article-title":"P-pillesvigt\u2013antagelig pa grund af interaktion med fenemal","volume":"139","author":"Fanoe","year":"1977","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.contraception.2010.06.013_bb0095","first-page":"3008","article-title":"Grossesses sous contraceptifs oraux chez les patientes recevant des barbituriques","volume":"4","author":"Gagnaire","year":"1975","journal-title":"Nouv Presse Med"},{"key":"10.1016\/j.contraception.2010.06.013_bb0100","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2006.00629.x","article-title":"Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy","volume":"47","author":"Galimberti","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0105","first-page":"1451","article-title":"Medikament\u00f6se Enzyminduktion und hormonale Kontrazeption","volume":"95","author":"Hempel","year":"1973","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.contraception.2010.06.013_bb0110","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2165\/00003495-197612060-00003","article-title":"Drug stimulated biotransformation of hormonal steroid contraceptives: clinical implications","volume":"12","author":"Hempel","year":"1976","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2010.06.013_bb0115","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1528-1167.2005.00605.x","article-title":"Serum valproate levels with oral contraceptive use","volume":"46","author":"Herzog","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0120","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000344167.78102.f0","article-title":"Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use","volume":"72","author":"Herzog","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2010.06.013_bb0125","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0140-6736(74)90593-5","article-title":"Anti-epileptic drugs and failure of oral contraceptives","volume":"1","author":"Janz","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.06.013_bb0130","first-page":"82","article-title":"Antiepileptika und die sicherheit oraler kontrazeptiva","volume":"151","author":"Janz","year":"1975","journal-title":"Bibl Psychiatr"},{"key":"10.1016\/j.contraception.2010.06.013_bb0135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5694\/j.1326-5377.1989.tb136691.x","article-title":"Inadvertent pregnancies in oral contraceptive users","volume":"150","author":"Kovacs","year":"1989","journal-title":"Med J Aust"},{"key":"10.1016\/j.contraception.2010.06.013_bb0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.seizure.2007.11.017","article-title":"Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites","volume":"17","author":"Ohman","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.contraception.2010.06.013_bb0145","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1997.tb01123.x","article-title":"Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy","volume":"38","author":"Rosenfeld","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.contraception.2010.06.013_bb0160","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine plasma levels","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2010.06.013_bb0165","first-page":"2236","article-title":"Twee pati\u00ebnten met hersenmetastasen die zwanger werden tijedens fenyto\u00efnegebruik","volume":"136","author":"van der Graaf","year":"1992","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.contraception.2010.06.013_bb0170","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/WNL.0b013e3181bd8295","article-title":"Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives","volume":"73","author":"Wegner","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2010.06.013_bb0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0010-7824(86)90044-2","article-title":"Contraception by Norplant subdermal capsules is not reliable in epileptic patients on treatment on anticonvulsant treatment","volume":"33","author":"Haukkamaa","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.06.013_bb0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0010-7824(86)90018-1","article-title":"Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants","volume":"33","author":"Odlind","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.06.013_bb0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-005-0064-4","article-title":"Failure of Implanon contraception in a patient taking carbamazepine for epilepsia","volume":"273","author":"Schindlbeck","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2010.06.013_bb0190","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/j.1875-9114.1998.tb03161.x","article-title":"Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy","volume":"18","author":"Shane-McWhorter","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.contraception.2010.06.013_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","article-title":"Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.06.013_bb0200","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1528-1157.1997.tb01240.x","article-title":"A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers","volume":"38","author":"Bartoli","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0205","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1528-1157.2003.55602.x","article-title":"Effects of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0210","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/WNL.50.4.1146","article-title":"Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol","volume":"50","author":"Eldon","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2010.06.013_bb0215","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1528-1157.1999.tb00779.x","article-title":"Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women","volume":"40","author":"Fattore","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0220","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.clinthera.2004.11.019","article-title":"Effect of Zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women","volume":"26","author":"Griffith","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.contraception.2010.06.013_bb0225","first-page":"141","article-title":"An evaluation of the interaction between tiagabine and oral contraceptives in female volunteers","volume":"4","author":"Mengel","year":"1994","journal-title":"J Pharm Med"},{"key":"10.1016\/j.contraception.2010.06.013_bb0230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1528-1157.2002.57701.x","article-title":"Levetiracetum does not alter the pharmacokinetics of an oral contraceptive in healthy women","volume":"43","author":"Ragueneau-Majlessi","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2010.06.013_bb0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0009-9236(95)90172-8","article-title":"Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive","volume":"58","author":"Saano","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.contraception.2010.06.013_bb0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.2005.02539.x","article-title":"The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects","volume":"61","author":"Sidhu","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2010.06.013_bb0245","first-page":"102","article-title":"Pill method failures","volume":"100","author":"Sparrow","year":"1987","journal-title":"N Z Med J"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410003914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410003914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:09:09Z","timestamp":1757880549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410003914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0010782410003914"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.06.013","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of hormonal contraception among women taking anticonvulsant therapy","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2010.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}